Products

What will AGI do for Alglucosidase alfa?

This classification denotes an enzyme replacement preparation with the molecular formula C4758H7262N1274O1369S35, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DTI67O9503, more generally known as alglucosidase alfa. European Medicines Agency schedules alglucosidase alfa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21275. The term ALGLUCOSIDASE ALFA is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, no. 1, 2005, list 53. Most nations schedule Alglucosidase alfa under HS 35079090 and SITC 51691. SMILES:. As of Q4 2014, ALGLUCOSIDASE ALFA remains the US FDA Preferred Term for this commodity. . Alglucosidase alfa bears US NLM identifiers UMLS ID C1703294 and NCI Concept Code C65221.

How AGI delivers it

Four ways AGI delivers for Alglucosidase alfa

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Alglucosidase alfa, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Alglucosidase alfa, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Alglucosidase alfa connects

measured by

  • Bacterial Endotoxin Contentmodel
  • Enzymatic Activitymodel
  • Glycosylation Profilemodel
  • Protein Puritymodel